---
title: "Barclays raised the target price for Thermo Fisher Scientific from $490.00 to $550.00"
description: "Barclays raised the target price for Thermo Fisher Scientific from $490.00 to $550.00"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256908737.md"
published_at: "2025-09-11T11:19:22.000Z"
---

# Barclays raised the target price for Thermo Fisher Scientific from $490.00 to $550.00

Barclays raised the target price for Thermo Fisher Scientific from $490.00 to $550.00

### Related Stocks

- [TMO.US - Thermo Fisher Scentific](https://longbridge.com/en/quote/TMO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Prospera Financial Services Inc Reduces Stock Holdings in Thermo Fisher Scientific Inc. $TMO | Prospera Financial Services Inc reduced its holdings in Thermo Fisher Scientific Inc. by 25.9% in Q3, now owning 14,407  | [Link](https://longbridge.com/en/news/275597600.md) |
| Thermo Fisher Scientific EVP Gianluca Pettiti Reports Sale of Common Shares | Gianluca Pettiti, EVP of Thermo Fisher Scientific Inc., reported the sale of common shares. The full filing is available | [Link](https://longbridge.com/en/news/275660275.md) |
| Cornerstone Investment Partners LLC Makes New Investment in Thermo Fisher Scientific Inc. $TMO | Cornerstone Investment Partners LLC has acquired a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing 85, | [Link](https://longbridge.com/en/news/275737805.md) |
| Thermo Fisher Scientific Inc.: Our Calculation Of Intrinsic Value | Thermo Fisher Scientific Inc. is analyzed using a DCF model, revealing an intrinsic value of approximately $187 per shar | [Link](https://longbridge.com/en/news/275929587.md) |
| William Blair Reaffirms Their Buy Rating on Thermo Fisher (TMO) | William Blair analyst Matt Larew has reaffirmed a Buy rating on Thermo Fisher (TMO), with shares closing at $546.76. The | [Link](https://longbridge.com/en/news/275467271.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.